Document text
Principal Investigator: Ke Cheng
Organization: COLUMBIA UNIV NEW YORK MORNINGSIDE
Fiscal Year: 2024
Award: $735,942
Funding agency: National Heart Lung and Blood Institute
PROJECT SUMMARY
Studies have demonstrated that adult stem cells such as mesenchymal stem cells (MSCs) repair
myocardial infarction (MI) or ischemia/reperfusion (I/R) injury by indirect paracrine mechanisms rather than by
differentiation and tissue replacement. In the past decade, exosomes have emerged as promising cell-free
agents for treating ischemic injury. Several exosome-based therapeutic companies have launched early phase
clinical trials. Like most therapeutics, there is an urgent need for effective delivery strategy to ensure a
sufficient number of exosomes to reach the injured tissue. Since they are nanosized natural lipid bilayer
particles, one option is vascular delivery. However, high and repeated dosing is needed due to a large degree
of off-target distribution to the mononuclear phagocyte system and other organs, such as the liver, spleen and
lungs. Moreover, MSC-derived exosomes (MSC-XOs) need to compete with naturally existing exosomes in
body fluids. Cellular binding and uptake of MSC-XOs also hinder the therapeutic effects. Novel approaches are
required to deliver therapeutic exosomes to cells in injured tissues. Ideally, modified exosomes should 1)
reduce the clearance by the mononuclear phagocyte system, 2) bind to injured blood vessels, and 3) be
efficiently uptake by target cell types in injured tissues. It has been established that acute MI can induce
vascular damage and expose components of the subendothelial matrix including collagen, fibronectin and von
Willebrand factor (vWF) to recruit platelets. Platelets can bind to and accumulate on injured vasculature
following MI. Instead of generically modifying the parental cells or chemically engineering exosomes, we used
platelet membranes to envelope exosomes (to make P-XOs) and increase their macropinocytosis-mediated
cellular internalization, and their ability to target the injured tissue. In this proposed study, we plan to
investigate the fabrication, characterization and toxicity of P-XOs (AIM 1). After that, we will test the therapeutic
effect of P-XOs on a mouse model (AIM 2) and a porcine model (AIM 3) with cardiac injury. Our study will
provide new insights on cellular internalization mechanism of exosomes, targeting properties and mechanism
of the P-XOs treatment. Together, the proposed mechanistic and translational experiments will provide a
scientific premise to understand system administrated exosomes while suggesting new approaches for
promoting targeting and therapeutic effect of therapeutic exosomes.
Terms: <Acute Lung Injury><Acute Pulmonary Injury><Acute myocardial infarct><Acute myocardial infarction><Animal Model><Animal Models and Related Studies><Animals><Applications Grants><Assay><Binding><Bioassay><Biological><Biological Assay><Biology><Biomedical Engineering><Blood Platelets><Blood Vessels><Blood flow><Body Fluids><Body Tissues><Cardiac infarction><Cardiovascular Diseases><Cardiovascular Models><Cell Body><Cells><Chemical Engineering><Clinical Trials><Cold-Insoluble Globulins><Collagen><Development><Dimensions><Dose><Endothelium><Engineering><Ensure><Exposure to><Extravasation><FN1><Family suidae><Fibronectin 1><Fibronectins><Grant><Grant Proposals><Heart><Heart Injuries><Homing><Human><Hybrids><In Vitro><Infusion><Infusion procedures><Injury><Interdisciplinary Research><Interdisciplinary Study><Intravenous><Ischemia><Ischemic Heart><Ischemic Heart Disease><Ischemic myocardium><LETS Proteins><Large External Transformation-Sensitive Protein><Leakage><Lipid Bilayers><Liver><Lung><Lung Diseases><Lung Respiratory System><Macrophage><Malignant Cell><Marrow platelet><Mechanics><Mediating><Membrane><Mesenchymal Progenitor Cell><Mesenchymal Stem Cells><Mesenchymal progenitor><Mesenchymal stromal/stem cells><Modern Man><Molecular Interaction><Mononuclear><Multidisciplinary Collaboration><Multidisciplinary Research><Myocardial><Myocardial Infarct><Myocardial Infarction><Myocardial Ischemia><Myocardial Ischemic Reperfusion Injury><Myocardial Reperfusion Injury><Mφ><NIH><Names><National Institutes of Health><Nature><Opsonic Glycoprotein><Opsonic alpha(2)SB Glycoprotein><Organ><Outcome><Paper><Patients><Phagocytes><Phagocytic Cell><Pigs><Platelets><Postdoc><Postdoctoral Fellow><Progenitor Cells><Property><Pulmonary Diseases><Pulmonary Disorder><Regenerative Medicine><Regenerative research><Reperfusion Therapy><Research><Research Associate><Ristocetin Cofactor><Ristocetin-Willebrand Factor><Rodent Model><Safety><Science><Scientist><Societies><Spillage><Spleen><Spleen Reticuloendothelial System><Suidae><Surface><Swine><System><Testing><Therapeutic><Therapeutic Effect><Thrombocytes><Tissues><Toxic effect><Toxicities><United States National Institutes of Health><Ventricular><adult progenitor><adult stem cell><alpha 2-Surface Binding Glycoprotein><amebocyte><bio-engineered><bio-engineers><bioengineering><biologic><biological engineering><cancer cell><cardiac infarct><cardiac injury><cardiac ischemia><cardiac repair><cardiovascular disorder><cell engineering><cell type><cellular engineering><combat><coronary attack><coronary infarct><coronary infarction><coronary ischemia><developmental><disease of the lung><disorder of the lung><early clinical trial><early phase clinical trial><engineered exosomes><exosome><experiment><experimental research><experimental study><experiments><extracellular vesicles><fabrication><first in man><first-in-human><graduate student><heart attack><heart infarct><heart infarction><heart ischemia><heart repair><hepatic body system><hepatic organ system><infusions><injured><injuries><insight><interest><intravenous injection><ischemia injury><ischemic injury><lipid bilayer membrane><lung disorder><mechanic><mechanical><membrane structure><mesenchymal stromal progenitor cells><mesenchymal-derived stem cells><minority student><model of animal><mouse model><murine model><myocardial ischemia/hypoxia><myocardium ischemia><name><named><naming><nano particle><nano sized><nano-sized particle><nanoparticle><nanosized><nanosized particle><new approaches><novel approaches><novel strategies><novel strategy><paracrine><particle><pig model><piglet model><porcine><porcine model><post-doc><post-doctoral><post-doctoral trainee><pre-clinical study><preclinical study><progenitor cell delivery><progenitor delivery><programs><pulmonary><recruit><regenerate new tissue><regenerate tissue><regenerating damaged tissue><regenerating tissue><regeneration research><regeneration studies><regenerative studies><repair><repaired><reperfusion><replacement tissue><research associates><site targeted delivery><somatic progenitor><somatic stem cell><stem><stem cell delivery><stem cell derived exosomes><stem cell exosomes><stem cells><suid><swine model><targeted delivery><therapeutic evaluation><therapeutic testing><tissue regeneration><tissue regrowth><tissue renewal><tissue specific regeneration><training opportunity><uptake><vascular><von Willebrand Factor><von Willebrand Protein>